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Abstract
Introduction
Zoonotic diseases have varying public health burden and socio-economic impact across
time and geographical settings making their prioritization for prevention and control impor-
tant at the national level. We conducted systematic prioritization of zoonotic diseases and
developed a ranked list of these diseases that would guide allocation of resources to
enhance their surveillance, prevention, and control.
Methods
A group of 36 medical, veterinary, and wildlife experts in zoonoses from government,
research institutions and universities in Kenya prioritized 36 diseases using a semi-quanti-
tative One Health Zoonotic Disease Prioritization tool developed by Centers for Disease
Control and Prevention with slight adaptations. The tool comprises five steps: listing of zoo-
notic diseases to be prioritized, development of ranking criteria, weighting criteria by pair-
wise comparison through analytical hierarchical process, scoring each zoonotic disease
based on the criteria, and aggregation of scores.
Results
In order of importance, the participants identified severity of illness in humans, epidemic/
pandemic potential in humans, socio-economic burden, prevalence/incidence and availabil-
ity of interventions (weighted scores assigned to each criteria were 0.23, 0.22, 0.21, 0.17
and 0.17 respectively), as the criteria to define the relative importance of the diseases. The
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top five priority diseases in descending order of ranking were anthrax, trypanosomiasis,
rabies, brucellosis and Rift Valley fever.
Conclusion
Although less prominently mentioned, neglected zoonotic diseases ranked highly com-
pared to those with epidemic potential suggesting these endemic diseases cause substan-
tial public health burden. The list of priority zoonotic disease is crucial for the targeted
allocation of resources and informing disease prevention and control programs for zoono-
ses in Kenya.
Introduction
Pathogens of zoonotic origin form two-thirds of all pathogens infectious to man including
newly emergent infections [1, 2]. Whereas the public health burden and socio-economic
impact of these zoonotic pathogens vary over time and across geographical settings, their
impact is often underestimated due to limited surveillance and paucity of disease burden data
in most developing countries. In most cases, zoonotic diseases that cause epidemics are better
characterized and tend to attract more attention and investments in prevention and control
among policy makers nationally and internationally compared to endemic zoonotic diseases
that heavily impact rural communities in developing countries [3–5]. For instance, the eco-
nomic impact of the 2006–2007 outbreak of Rift Valley Fever (RVF) in Kenya was well-
characterized and estimated at US$32 million [6], whereas the economic impact of the more
commonly occurring endemic zoonotic diseases such as rabies and anthrax remains largely
undetermined. For effective management of all zoonotic diseases at the national level in the
context of other competing human and animal health threats, prioritization of zoonotic dis-
eases is a key management tool in informing resource allocation.
Several approaches to prioritization of diseases using either qualitative, semi-quantitative or
quantitative techniques have been developed [7]. Quantitative methods are best applied where
empirical data such as disease burden and socio-economic impact exist, and where there are
effective surveillance systems [8–10]. Semi-quantitative and qualitative methods are used
where data necessary for prioritization is either insufficient or not available [7, 9]. While selec-
tion of the approach to employ differs with the data available, the prioritization process should
follow a systematic process that is transparent, replicable and consultative to ensure validity of
outcome [7].
The control of zoonotic diseases and events requires close collaboration of human and ani-
mal health sectors and their stakeholders in order to effectively and efficiently reduce their
emergence and spread [4, 11, 12]. In 2012, Kenya started the implementation of the “One
Health” approach through the formation of an inter-ministerial coordination unit referred to
as the Zoonotic Disease Unit (ZDU). The mandate of the ZDU is to enhance collaboration
between the human, animal, and environmental health sectors for the prevention, control and
management of zoonotic diseases [13]. Through the ZDU, Kenya developed a five-year (2012–
2017) strategic plan for the implementation of one health in the country and listed zoonotic
diseases of importance in Kenya but these were not ranked in order of priority [13]. Here, we
conducted a semi-quantitative prioritization of zoonotic diseases ranking them in order of rela-
tive importance to guide allocation of resources for development and implementation of pre-
vention and control strategies for these diseases in Kenya.
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Methods
The prioritization of zoonotic diseases was carried out through a facilitated consultative pro-
cess involving 36 experts in zoonoses from the public health (n = 19), animal health (n = 15)
and wildlife health (n = 2), during a three day workshop in September 2015. To select partici-
pants, institutions (government, research and academia) and departments that work on zoono-
ses in areas of surveillance, research and diagnostics on both human and animal health were
identified and invitations sent out requesting for experts on zoonoses. Those who were nomi-
nated voluntarily agreed to participate. About 20% of the zoonoses experts selected by their
institutions had not previously participated in ZDU activities. To minimize systematic bias
arising from participants from same institutions ‘thinking the same way’, participants from
same institutions and expertise were purposively placed in different groups.
Selection of prioritization tool
Quantitative data on zoonotic diseases in Kenya is only available for a select few diseases. As a
result, a semi-quantitative tool developed by the US Centers for Disease Control and Preven-
tion was used [9]. We made modifications to the One Health Zoonotic Disease Prioritization
(OHZDP) tool so that it could be administered to five groups each consisting of 6–7 persons,
rather than to a maximum of 12 individuals as previously reported[9]. Each group comprised
of two to three public health and animal health professionals working in surveillance, disease
control, laboratory, academic and research. The prioritization process consisted of five steps:
identification of zoonotic diseases to be prioritized, development of measurable criteria for
ranking these diseases, pairwise comparison of the criteria in order to assign weights to each
disease, scoring each disease based on the criteria using a decision tree analysis, and aggrega-
tion of scores taking into consideration the weighted criteria [9].
Selection of zoonotic diseases to be prioritized
Starting with a list of 30 zoonotic diseases populated by experts as diseases relevant to Kenya
during the formation of the ZDU in 2012 [13], participants reviewed the list to include all zoo-
notic diseases that are suspected or known to be present in Kenya or the East African region in
the last 20 years (1995–2015) since those diseases that may not be present in the country have
potential for introduction from the region through travel and trade such as Ebola virus disease.
From this process, Q-fever, Middle East Respiratory Syndrome Coronavirus (MERS CoV), chi-
kungunya, taeniasis, sarcopsis, histoplasmosis hantavirus, and Lassa virus were added to the
list. In addition, participants included anti-microbial resistance (AMR) pathogens due to the
potential transmission of AMR microbes or resistance genes from livestock to humans [11, 14],
while tularemia, toxoplasmosis and trichinosis were removed from the list leaving a final list of
36 diseases.
Selection and weighting of criteria for ranking the diseases
Each group was tasked to come-up with a set of five criteria that were subsequently discussed
in a plenary session to produce a combined final list of five criteria that were used to evaluate
the diseases, (Table 1). From a list of nine criteria, four criteria were dropped after the plenary
discussion to limit the number to the five as suggested by the OHZDP tool [9]. First, ‘possibility
of rapid gains following public health intervention’ was deemed to fall in part within the crite-
ria evaluating the potential for effective interventions. Secondly the ‘epidemic potential of zoo-
notic disease’ was found to be a more robust measure of public health impact than ‘ease of
animal to human transmission’ a metric that would assess ease of pathogen transmission from
Prioritization Zoonotic Diseases in Kenya
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one host to another. Thirdly, for ‘socio-economic, food security and safety’ as a criteria the par-
ticipants argued that the socio-economic impact would encompass impact of a disease on food
security to communities while food safety on the other hand was felt to be of relatively lesser
importance. Finally, most of the participants argued that ‘bioterrorism’ is of much lesser rela-
tive importance in our setting as opposed to developed countries where there is low burden of
zoonotic diseases.
Using a Microsoft Excel1 program from the OHZDP tool by groups, a semi-quantitative
analytic hierarchy process was used to assign the most important criteria the highest weight,
and the least important criteria the lowest weight [9, 10, 15]. Subsequently, each group ranked
the five criteria in order of importance and the group results were combined to produce the
overall rank and weight of the criteria. This process assessed the consistency of responses,
ensuring adherence to both completeness and transitivity of the group choices for each criteria,
which are traditionally used as ‘gold standard’ for rational choice in normative decision theory
[7, 9]. A consistency ratio of 0.01 or less was considered satisfactory.
Next, a set of categorical questions against each of the criteria were developed through con-
sensus among the participants. A slight modification from the standard OHZDP tool methods
was made in that multiple questions were developed for some criteria. Each of the categorical
questions had either binomial (e.g. yes/no) or multinomial answers. The multinomial answers
were ordinal in nature with a maximum of 5 categories (e.g. scoring 0–4) for each question
used to assess the criterion (Table 1). Where multiple questions existed for one criteria, scores
were summed up.
Participants were provided with available epidemiologic data on each of the diseases from
both published and unpublished literature including: reported case fatality rate, human mor-
bidity and mortality rates, Disability Adjusted Life Years (DALYs), evidence of sustained trans-
mission in humans, animal disease burden and vector information, availability of effective
treatment and vaccines for use in animals and humans and the estimates of the socio-economic
impact of the diseases.
Table 1. Ranking criteria, associated weighting for each criteria, and the categorical questions for each criteria and response options used to
examine each of the 36 zoonotic diseases selected for prioritization in Kenya.
Criteria (weighted scores) Question (s) Responses and categories (score)
Severity of illness in
humans (0.23)
What is the Case Fatality Rate of the Zoonotic Disease if untreated? 0–5% (0); 6–20% (1); 21–50% (2); >50% (3)
What is the disability weight of the Zoonotic Disease, based on
WHOGlobal Burden of Disease classification?
0.0–0.025 (0); 0.026–0.144 (1); 0.145–0.28 (2) >0.283
(3)
Epidemic potential of ZD
(0.22)
Has the Zoonotic Disease caused an outbreak in the last 20 years? Nationally (2); Regionally* (1); Globally (0)
Howmany counties are/were affected by the Zoonotic Disease in a
year during the last outbreak?
5 (0); 6–10 (1); >10 (2)
Social Economic Impact
(0.21)
Does the Zoonotic Disease cause >5% decrease in animal
productivity (death, morbidity)?
No (0); Yes (1)
Is the Zoonotic Disease associated with restrictions in trade or free
movement of animals or humans?
No (0); Yes (1)
Prevalence/Incidence of
disease (0.17)
What is the Zoonotic Disease prevalence in humans or animals? <1% (0); 1–5% (1); 5–10% (2); 11–30% (3); >30% (4)
Howmany counties are affected by the Zoonotic Disease? 5 (0); 6–10 (1); >10 (2)
Potential for effective
intervention (0.17)
Are there effective vaccines or treatment measures for the Zoonotic
Disease in animals or humans?
Vaccine and treatment (2); Treatment but no vaccine
(1); No vaccine and no treatment (0)
*Referring to Eastern Africa countries
doi:10.1371/journal.pone.0161576.t001
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To assign each of the diseases a measure of severity of illness in humans, case fatality rate
(CFR) in untreated patients and the Disability Adjusted Life Years (DALYs) were used as
proxy measurements [16] (Table 1). For diseases that present with multiple syndromes such as
RVF, which has mild to hemorrhagic forms, the CFR for the most severe syndrome was consid-
ered. The disability weights as presented in the WHO Global Burden of Disease study were
used. Diseases with unknown CFRs or DALYs were assigned CFRs or DALYs of diseases with
similar syndromes in humans. For example DALYs for the two clinical syndromes of dengue
virus infection, dengue fever and dengue hemorrhagic fever were used to assign scores for viral
hemorrhagic fevers including RVF, Ebola, Yellow fever and Marburg. DALYs for episodes of
malaria was used to assign scores for Q-fever.
Information on zoonotic diseases associated with trade restrictions was derived from a list
of transboundary diseases by the World Organization for Animal Health (OIE). This list (list A
and B) specifies transmissible diseases with potential for rapid spread across national borders
with resultant socio-economic and/or public health consequence and are associated with
restrictions to international trade of animals and animal products [17]. Diseases on this list
such as RVF, anthrax and Q-fever were scored ‘yes’ while those not on the list such as Ebola,
WNV and CCHF were scored a ‘no’ on the question on restrictions in trade or free movement
of animals or humans.
Ranking and aggregation of scores for the zoonotic diseases
Using a decision tree approach described in the OHZDP, each group then proceeded to score
each zoonotic disease independently based on the answers to the categorical questions for each
weighted criterion [9]. Where country level data were not available, data from the East Africa
region was used. In the absence of any published data from Kenya and the region, expert opin-
ion was used to assign a disease to a level. This process was repeated for all 36 diseases on the
list.
For each disease, the weighted scores for each criteria were summed to obtain a total
weighted score by group. Subsequently an average weighted score (from all five groups) was
obtained and normalized in relation to the maximum score, yielding a normalized final score
within a range of 1 to 0 that was used to rank the diseases. This was a modification from the
standard OHZDP tool method where facilitators assign scores for each disease in one spread-
sheet and the individual weighted scores are aggregated and normalized [9] Thereafter, the
ranked disease list was reviewed during a plenary session.
Sensitivity analysis
To assess the robustness of the prioritization outcome, variability in weighting of the criteria,
consensus building in groups and expert opinion scoring of disease data were evaluated. First,
the five criteria were given equal weights of 1 to obtain normalized scores for each disease as
described [9, 18]. Next, each of the five criteria was systematically removed from the process to
obtain normalized scores for each disease. Finally, each of the five groups was removed to
assess the impact each group had on the final normalized scores. Pearson’s product-moment
correlation was used to assess the relationship between normalized scores obtained using the
OHZDP tool that produced the ranked priority disease list reported here and the adjusted
scores, assessing impact of criteria weight and contribution of each criteria and group respec-
tively. Pearson’s correlation coefficient was considered significant at p-value<0.05.
Ethical approval was not sought since the activity was not human subject’s research, the pri-
mary intent was public health practice using data that is publicly available. Informed consent
was not sought from the participants and all data was analyzed anonymously.
Prioritization Zoonotic Diseases in Kenya
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Results
The final list of diseases to be prioritized included 36 diseases/pathogens. The distribution of
calculated weight and rank for each of the five criteria from each of the five groups is given in
Table 2. The criterion evaluating illness in humans was ranked highest in three of the five
groups and second in the remaining groups and ranked highest overall.
Overall, the top five priority diseases in descending order were anthrax, trypanosomiasis,
rabies, brucellosis and RVF (Table 3). Viral and bacterial zoonoses made up 60% of zoonotic
pathogens at 36.1% and 25% respectively; zoonoses caused by helminths were 13.9%, proto-
zoan and fungi 8.3% each, ecto-parasites 5.5% and others 2.8%. Overall, zoonotic diseases with
limited data including West Nile virus fever, Lassa fever, diphyllobothriasis or no local or
regional data including, hantavirus fever, and histoplasmosis generally ranked lowest since two
of the criteria, epidemic potential and prevalence of disease relied on presence of local data.
For severity of illness, diseases with a CFR of>50% such as Ebola, Marburg, human African
trypanosomiasis (HAT) and rabies were scored highly and diseases/events with a CFR 5%
including RVF, brucellosis, salmonellosis and AMR scored lower. While pathogens classified as
viral hemorrhagic fevers were generally scored higher on adjusted disability weights, HAT,
Ebola, rabies and yellow fever were assigned the highest score by three or more groups.
In the assessment of epidemic potential, endemic zoonotic diseases that are reported in
humans and animals annually in multiple counties in Kenya through the Ministry of Health’s
Integrated Disease Surveillance and Response (IDSR) System and the Directorate of Veterinary
Services surveillance system were assigned high scores. This includes diseases such as anthrax,
RVF, rabies, Q-fever, dengue fever and brucellosis.
High scores were assigned to anthrax, brucellosis, RVF andMycobacterium species, diseases
for which outbreaks in livestock are associated with high direct and indirect losses in produc-
tivity and market losses associated with quarantines and trade bans. Diseases that had reported
high prevalence and in multiple counties including brucellosis, schistosomiasis and RVF were
assigned high scores while diseases that had not been reported in Kenya or reported less than
1% prevalence in less than two counties including a number of viral hemorrhagic fevers (Ebola
and Marburg), plague, Lassa fever, hantavirus and fungal diseases including histoplasmosis
and cryptococcosis were assigned a score of 0.
Anthrax, brucellosis and most of the bacterial infections were scored highly for potential for
intervention since vaccines and treatments are available for humans or animals. However,
most of the viral diseases with the exception of RVF, yellow fever and influenza scored low in
this category due to the unavailability of vaccines and drugs.
Sensitivity analysis
There was a strong positive correlation between normalized scores and adjusted scores, produced
by the OHZDP tool, seen when comparing weighted and unweighted criteria [r (34) = 0.99,
Table 2. Ranking of criteria using analytical hierarchical process: criteria weight and rank for each of the groups.
Group Group 1 Group 2 Group 3 Group 4 Group 5 Overall ranking
Severity of illness 0.43–1 0.24–2 0.49–1 0.35–1 0.28–2 1
Epidemic potential 0.28–2 0.44–1 0.19–3 0.25–2 0.14–3 2
Socio-economic impact 0.17–3 0.10–4 0.07–4 0.21–3 0.48–1 3
Prevalence of disease in humans or animals 0.07–4 0.04–5 0.21–2 0.03–5 0.06–4 4
Interventions 0.05–5 0.18–3 0.04–5 0.16–4 0.05–5 4
Consistency ratio* 0.06 0.1 0.07 0.05 0.07 -
*A consistency ratio < 0.1 is acceptable
doi:10.1371/journal.pone.0161576.t002
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p< 0.05], when excluding each criteria from the model [r (34) (0.94–0.98), p< 0.05], and when
excluding each groups from the model [r(34) (0.94–0.98) p< 0.05], Fig 1.
Specifically, there were minimal changes in disease ranking for the first five diseases on the
final ranked disease list except when severity of illness in humans was excluded, where trypano-
somiasis dropped three levels (ranked 6th) and non-typhi salmonellosis moved up two levels
Table 3. Ranked Priority disease list for Kenya with ranking by criteria and normalized final scores, 2015.
Disease Overall ranking by criteria Normalized Final
scoresSeverity of
illness
Epidemic
potential
Socio-economic
impact
Prevalence of disease in
humans or animals
Available
Intervention
Anthrax 5 2 1 4 1 1
Trypanosomiasis 1 4 1 9 3 0.94
Rabies 4 5 3 5 1 0.93
Brucellosis 9 4 1 1 2 0.89
Rift Valley fever 9 1 1 2 5 0.87
Echinococcosis
(Hydatidosis)
7 7 6 3 3 0.73
Non Typhi Salmonellosis 12 2 6 7 1 0.7
Q fever* 11 6 5 1 4 0.69
Mycobacterium spps 7 6 2 8 7 0.67
Influenza and pandemics 8 8 2 9 6 0.64
Cysticercosis 12 8 4 5 3 0.62
Dengue 7 2 7 3 10 0.6
Leptospirosis 7 8 4 5 3 0.6
Schistosomiasis 11 8 9 3 3 0.58
Yellow fever 6 10 5 11 5 0.54
Rickettsiosis 10 8 10 6 3 0.52
Taeniosis* 14 9 7 5 3 0.51
Sarcopsis* 14 11 5 7 3 0.5
Cryptosporidiosis 13 9 8 4 4 0.49
Leishmaniasis 7 8 9 10 6 0.49
Ebola 2 14 4 13 9 0.48
Marburg 3 14 5 13 10 0.42
Crimean-Congo
hemorrhagic fever
5 11 6 9 10 0.42
Antimicrobial resistance* 14 3 7 9 8 0.42
Dermatophylosis 14 12 9 9 3 0.36
Cryptococcosis 12 12 10 9 4 0.36
Listeriosis 12 14 5 12 5 0.35
Aspergillosis 12 13 9 11 5 0.34
MERS-CoV* 14 16 6 8 10 0.34
Plague 14 15 9 13 6 0.32
Chikungunya* 10 9 9 8 10 0.31
West Nile Virus 10 12 9 10 10 0.24
Histoplasmosis* 13 15 10 13 5 0.22
Diphyllobothriosis 14 17 9 13 4 0.19
Hanta virus fever* 8 17 8 13 10 0.17
Lassa fever* 9 17 9 13 10 0.13
* Zoonotic diseases that were newly added to the list in 2015
doi:10.1371/journal.pone.0161576.t003
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(ranked 4th). Anthrax was ranked first regardless of weight of criteria and group contribution
and second when prevalence of disease in humans and animals was excluded.
Discussion
The top five diseases identified as priority zoonotic diseases in Kenya were anthrax, trypanoso-
miasis/HAT, rabies, brucellosis and RVF in descending order. Overall, neglected zoonotic dis-
eases ranked highly, highlighting the high burden and importance of non-epidemic diseases in
the local context. Among the top ten priority diseases in Kenya, five diseases (anthrax, trypano-
somiasis, rabies, brucellosis, and hydatidosis) have been listed as neglected zoonotic diseases by
WHO [5]. This highlights the importance of prioritizing diseases at country level as it presents
the opportunity to focus on diseases that have the greatest public health burden and not just
diseases that have greater global attention as the epidemic prone diseases.
Fig 1. Comparison of normalized scores obtained from the weighted criteria and (a) equal weights; (b) excluding each of the five
criteria and (c) excluding each of the five groups.
doi:10.1371/journal.pone.0161576.g001
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It has been suggested that neglected zoonotic diseases, which primarily impact poor rural
communities, are in part neglected due to underreporting and underestimation of disease bur-
den resulting from use of unreliable disease metrics extrapolated from scanty data [4, 19]. This
results in the systematic underweighting of these diseases and lower investments in prevention
and control programs by health authorities compared to emerging diseases with epidemic
potential that attract the attention of policy and political decision makers globally and in the
developed countries [4, 12, 19]. For example, in North America and Japan, viral hemorrhagic
fevers (Ebola and Marburg virus hemorrhagic fever and Lassa fever), epidemic diseases (Influ-
enza (H1N1) and severe acute respiratory syndrome), rabies, Nipah virus encephalitis and
prion diseases (variant Creutzfeldt-Jakob disease and Bovine spongiform encephalopathy)
were among the top five priority diseases, reflecting the focus on risk-based priority setting to
zoonotic diseases with high impact on public health and trade [9, 19]. Many of the endemic
diseases in Kenya are absent or low in prevalence in many of the developed countries further
reducing attention given to them. However, similar to Kenya the disease priority list in the
Netherlands was mostly endemic diseases including Toxoplasma gondii, campylobacter species
and Coxiella burnetti [18]
The prioritization work provided an opportunity to update the zoonotic disease list with
inclusion of newly reported zoonotic diseases/events in Kenya such as MERS CoV and antimi-
crobial resistance, an emerging global concern that is driven in part by transmission of drug-
resistant pathogens from livestock to humans through use of antimicrobials to maintain animal
health and increase livestock productivity [10]. However, this list should not be static and
should be reviewed regularly to take account of new data arising including of emerging infec-
tions such as ZIKA virus currently receiving attention across countries and diseases that are
could have been overlooked such as toxoplasmosis. In addition, in line with the goal of this
exercise and to identify and prioritize endemic zoonotic diseases with higher health burden
locally, higher weights were assigned to diseases with larger geographical occurrence nationally
as opposed to diseases that have occurred regionally or globally. Majority of emerging diseases
that have occurred globally or regionally such as Ebola hemorrhagic fever, highly pathogenic
avian influenza and Zika often receive funding from international agencies for preparedness
and response based on risk of occurrence and at times irrespective of local occurrence. So it
very likely in another setting depending on the goal of the prioritization exercise for these
major zoonotic diseases that have occurred globally to be scored higher. The prioritized disease
list provides a basis for the design of prevention and control programs for zoonoses, and alloca-
tion of resources to enhance zoonotic disease management in Kenya.
The OHZDP tool and similar approaches have been used previously using varied criteria
and different stakeholders [8–10, 18, 20, 21]. Use of this tool allowed for multi-stakeholder
groups to provide input from a broad base of experience for ranking of criteria and the consul-
tative nature would enhance buy-in of the final list of prioritized diseases by different sectors in
the country for future allocation of resources in zoonotic disease management programs. The
sensitivity analysis demonstrated that the weight of the criteria, the criteria used, and individual
groups did not have significant bias in our final ranking of the prioritized disease list. This
could likely be due to the systematic use of data provided for the groups, similar nature of the
criteria and questions developed by the groups, or an existing collaborative or shared vision of
the participants that made this slightly modified version of the OHZDP tool appropriate for
zoonotic disease prioritization in Kenya.
There were however, several limitations to this work. First, the decision tree analysis requires
metric measurements of disease occurrence, which were lacking for a number of diseases or that
were only available from limited studies that may not be representative of the entire country. In
addition, some of the disease metrics such as prevalence, OIE classification of diseases and case
Prioritization Zoonotic Diseases in Kenya
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fatality rates could not adequately evaluate all the diseases being prioritized such as AMR. In
cases where disease data were unavailable, experts provided estimates based on data from the
region or from diseases closest in epidemiology to those being examined hence introducing bias.
Use of multiple groups in assigning scores from expert opinion partly mitigated subjective bias
that is inherent in semi-quantitative scoring. Secondly, it has been recognized that disease met-
rics such as DALYS that have been generated with data largely from the developed world could
underestimate the public health burden of neglected endemic zoonotic diseases. Thirdly, we
used a slightly modified version of the OHZDP tool, hence our output may not be comparable
to outputs from other countries that used the standard version; additionally this modified
approach may not be appropriate in all settings, especially when individual over group opinion
is needed for buy-in and consensus building. Finally, the epidemiology of certain diseases in
Kenya could have resulted in overestimation of true burden in the country resulting in high
ranking of these diseases. For example, HAT is localized in western parts of Kenya while try-
panosomiasis in livestock caused by Trypanosome species that are largely non-zoonotic is asso-
ciated with high economic impact that resulted in high ranking of this disease despite the fact
no HAT case had been reported in the last decade. Similarly, outbreaks of anthrax are associated
with dramatic clinical disease events that render them easier to report and document.
Application of this modified version of the OHZDP tool allowed us to use qualitative and
quantitative data to generate metrics for ranking diseases in a larger group setting. It is important
to point out that while this disease list could be used to guide the allocation of limited resources
to control diseases that ranked highly, areas of collaboration in surveillance and research should
be explored for all diseases since it’s likely that the lack of data particularly for diseases such as
Hanta virus fever and histoplasmosis, that no surveillance programs are in place could have
influenced the final outcome. Investments in innovative collaborative multi-pathogen surveil-
lance and research programs to generate disease prevalence and burden data, and development
of effective disease prevention and control strategies in human and animal populations are some
key recommendations to enhance future prioritization exercises. The methods used here could
potentially be applied across different health sectors to rank public health needs.
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